This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wichmann, T. Articles by DeLong, M. R. Search for Related Content PubMed Articles by Wichmann, T. Articles by DeLong, M. R. Social Bookmarking                   What's this?

Parkinson's Disease and the Basal Ganglia: Lessons from the Laboratory and from Neurosurgery

Department of Neurology Emory University School of Medicine Atlanta, Georgia

Jerrold L. Vitek

Department of Neurology Emory University School of Medicine Atlanta, Georgia

Mahlon R. DeLong

Department of Neurology Emory University School of Medicine Atlanta, Georgia

During the last decade, a clearer understanding of the circuitry of the basal ganglia and their mode of operation has emerged. The basal ganglia are now viewed as parts of larger, segregated circuits that involve the thalamus and cerebral cortex. A pathophysiological model has been elaborated and tested in which Parkinsonian signs are viewed as resulting from increased activity of neurons in the "motor" portion of the internal pallidum, the major output nucleus of the basal ganglia, leading to increased inhibition of thalamocortical projection neurons and decreased activation of the precentral motor fields. Increased internal pallidal activity is thought to result from striatal dopamine loss, leading to decreased inhibition of the internal pallidum via a monosynaptic ("direct") striatopallidal pathway and to excessive excitatory glutamatergic drive via a polysynaptic ("indirect") striatopallidal pathway. Because current medical therapies for Parkinson's disease, aimed at systemically replacing dopamine, often lose their effectiveness after several years, with patients suffering from motor fluctuations and drug-induced dyski nesias, several new therapeutic strategies have been developed. In addition to the transplantation of dopaminergic tissue, other strategies attempt to reduce increased basal ganglia outflow directly by the placement of stereotactic lesions into the sensorimotor portion of the internal pallidum (pallidotomy) or by the chronic electric stimulation of the subthalamic nucleus. Preliminary results suggest that these new techniques may lead to significant improvement in Parkinsonian signs, motor fluctuations, and drug- induced dyskinesias. The Neuroscientist 1:236-244, 1995

Key Words: KEY WORDS Parkinson's disease • Basal ganglia • Stereotactic surgery • Pallidotomy • Globus pallidus • Subthalamic nucleus

The Neuroscientist, Vol. 1, No. 4, 236-244 (1995)
DOI: 10.1177/107385849500100407


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?